The Scientific Symposium is part of the in-person event held at Staglin Family Vineyard that will also be streamed online for free to anyone around the world.
2022 KEYNOTE SPEAKER
Regina E. Dugan, PhD
President & CEO, Wellcome Leap, Inc.
Regina E. Dugan, PhD is an internationally recognized business executive, producer, engineer-artist, taskmaster, and product developer. She has led world-class, global teams, and hundred-million to multi-billion dollar efforts to deliver breakthrough products at Facebook, Google, Motorola, as the 19th Director, and first woman to lead, the Defense Advanced Research Projects Agency (DARPA). FORTUNE described Dugan as one of the world’s leading experts on product innovation, “the kind that unhinges old ways of operating, juices competition and creates new growth.” She has been named to the Verge 50 list, Fast Company’s ‘Most Creative People in Business 1000,’ CNN’s ‘Top 10 Thinkers’, and CNBC’s ‘NEXT LIST’. As executive producer, she has 4 Annie Awards, 1 Emmy, and 1 OSCAR nomination.
She holds her PhD in mechanical engineering from Caltech, where she is a Distinguished Alumnus (one of 256 historical honorees including Carver Mead and Gordon Moore) and her BS/MS from VaTech, where she was inducted to Academy of Engineering Excellence.
The 2022 Rising Star Award winners will be announced at the Scientific Symposium. They will present their awarded research projects and participate in a Q&A session with those in attendance.
COMPASS Pathways is sponsoring each of the three 2022 Rising Star Awards.
Ekaterina Malievskaia, PhD, Chief Innovation Officer and Co-Founder of COMPASS Pathways will provide introductory comments.
2022 FEATURED SPEAKER
Christopher M. Palmer, MD
Director of the Department of Postgraduate and Continuing Education at McLean Hospital and Assistant Professor of Psychiatry at Harvard Medical School
Christopher M. Palmer, MD is a Harvard psychiatrist and researcher working at the interface of metabolism and mental health. He is the Director of the Department of Postgraduate and Continuing Education at McLean Hospital and an Assistant Professor of Psychiatry at Harvard Medical School. For over two decades, he has held leadership roles in psychiatric education at Harvard, McLean Hospital, and nationally. He has also continued to practice psychiatry, working with people who have treatment-resistant mental illness using a variety of standard treatments.
He has been pioneering the use of the medical ketogenic diet in the treatment of psychiatric disorders—conducting research in this area, treating patients, publishing academic articles, and speaking globally on this topic. More broadly, he is interested in the roles of metabolism and mitochondrial function on brain health, and how these insights might lead to a better understanding of mental disorders and the development of more effective treatment and prevention strategies.